Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin.
Frame
J N
JN
National Naval Medical Center, Bethesda, Maryland.
Mulvey
K P
KP
Phares
J C
JC
Anderson
M J
MJ
D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000628:therapy; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D008875:Middle Aged; D017713:Platelet Transfusion; D011655:Pulmonary Embolism / Q000188:drug therapy; D012008:Recurrence; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy*; D013924:Thrombophlebitis / Q000188:drug therapy
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D006493:Heparin